Intelligence Platform

Patents

Browse 69 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8846034

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

HALOZYME, INC. · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8815558

Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceu

HALOZYME, INC. · Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8772246

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765685

Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)

HALOZYME, INC. · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580252

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8568713

Super fast-acting insulin compositions

HALOZYME, INC. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450470

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431124

Methods for treating a disease characterized by an excess of hyaluronan by administering a

HALOZYME, INC. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431380

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318154

Super fast-acting insulin compositions

HALOZYME, INC. · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8257699

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8202517

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8105586

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871607

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846431

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7829081

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7786096

Inhibition of antigen presentation with poorly catabolized polymers

HALOZYME, INC. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7767429

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718428

Myeloid colony stimulating factor and uses thereof

HALOZYME, INC. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544499

Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceu

HALOZYME, INC. · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7538097

Inhibition of antigen presentation with poorly catabolized polymers

HALOZYME, INC. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted